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Matrix metalloproteinases (MMPs) are a family of 
inducible enzymes that degrade extracellular matrix 
components, allowing cells to traverse connective 
tissue structures efficiently. Specific tissue inhibitors 
(TIMPs) function as physiologic inhibitors of MMP 
activity. Because neovascularization may require 
various proteinases, we characterized the profile of 
metalloenzyme production by microvascular endo-
thelial cells (MEC) and the modulation of expression 
by phorbol esters (PMA) and by the physiologically 
relevant cytokines tumor necrosis factor-a (TNF-a), 
basic fibroblast growth factor, and interferon-y. 
MMP expression by MEC and large-vessel human 
umbilical vein endothelial cells (HUVEC) was deter-
mined by enzyme-linked immunosorbent assay, im-
munoprecipitation, Northern hybridization, and 
transfection assays. Constitutive expression of MMPs 
by endothelial cells was low. PMA stimulated the 
production of collagenase, stromelysin, 92-kDa gela-
tinase, and TIMP-1 in both endothelial cell types. 
TIMP-2 was constitutively expressed by MEC and 
HUVEC, but was down-regulated by PMA. TNF-a 
induced an endothelial-cell-specific up-regulation of 
M icrovascular endothelial cells (MEC) differ from large-vessel endotheljal cells with regard to tbeir expression of integrins [1-5] and other cell adhesion mol.ecules [6,7] and in their response to injury [8]. Endothelial cells in vivo reside on a 
basement membrane, which includes type IV collagen, lamirun, 
heparin sulfate proteoglycans, and entactin [9]. During new vessel 
growth associated with wound healing, this stable matrix is dis-
rupted, and microvascular cells contact an interstitial matrix con-
taining type I collagen and elastin, and interact with various 
inflammatory mediators liberated by resident and migratory cells. 
After the acute phase, tissue remodeling <;>ccurs and eventually 
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collagenase with a concomitant inhibition of PMA-
induced TIMP-1 up-regulation, a response that is 
distinct from that of fibroblasts. Interferon-')' up-
regulated TIMP-1 production by MEC and blocked 
PMA and TNF-induced up-regulation of collagenase. 
Northern hybridization assays showed pretransla-
tional control of PMA-, basic fibroblast growth fac-
tor-, and TNF-a-induced MMP expression. Collage-
nase-promoter CAT constructs containing 2.28 kb of 
the 5' region of the collagenase gene dentonstrated 
transcriptional regulation. The potential physiologic 
relevance of such regulation was shown in an iu vitm 
migration assay. MEC were stimulated to migrate by 
wounding and exposure to TNF-a. Collagenase 
mRNA was prominently expressed by the migrating 
cells, as shown by itt situ hybridization. In sum, MEC 
have a unique profile of MMP expression and regula-
tion compared with other cell types, which may be 
important for wound healing and angiogenesis, par-
ticularly during the early phase of migration. Key 
words: JVOII11d healiuglaugiogenesislcollagellase/TNF-a. 
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mucb of the neovasculature, along with its accompanying newly 
formed matrix, regresses. Microvascular cell migration, brancrnng 
morphogenesis of newly forming blood vessels, and neovasculature 
dissolution result from a fine ly regulated balance of matrix depo-
sition and degradation. 
The matrix metalloproteinases (MMPs) are a gene family of 
enzymes that modulate the tumover of extracellular matri.." [1 0) . 
Three interstitial collagenases have been identified that possess the 
unique capacity to cleave native triple helical collagen types I , ll, 
and III [11-13]. The stromelysins have broad substrate specificity 
and are able to degrade proteoglycans, lamin.in, fibronectin, and the 
nonhelica1 domains of collagen types IV and IX [1 4]. There are two 
metallogelatinases that readily attack denatured collagens of all 
genetic types [15-18], as well as insoluble elastin and basement 
membranes. The 72-kDa gelatinase is produced by fibroblasts and 
osteoblasts; 92-kDa gelatinase is secreted principally by mononu-
clear phagocytes and eosinophils. Matrilysi.n, a low-molecular-
weight metalloenzyme, is produced by human mononuclear phago-
cytes [1.9] and has been reported in vm·ious tumors [20] and in 
postpartum rat uteri [21]. Matrilysin has broad and potent cata.lytic 
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act1v1ty against proteoglycans, elastin, lamini.n, fibronectin, and 
e ntactin [14]. Thus, as a family, MMPs have the capacity to degrade 
essentially all components of the extracellular matrix. 
The catalytic activity of MMPs is controlled, at least in part, by 
counter-regulatory proteins called TIMPs (tissue inhibitors of m e-
talloproteinases) . The TIMPs represent a small gene family of three 
members: TIMP, TIMP-2, and TIMP-3. TIMP is a 28- kDa g lyco-
protein that forms a very high affinity (K; = 10- 9 M), though 
noncovalent, complex with various MMPs [22]. TIMP-2 appears to 
be more specialized and is selectively secreted with 72-kDa gelati-
nase [23] . TIMP-3 is a very recently described matrix-associated 
inhibitor [24]. 
Chronic inflammatory conditions result in the restructuring of 
connective tissue and the formation of new blood vessels, and these 
remodeling events require the degradative activity of various 
proteinases. In nearly all cell types and tissues, there is little or no 
constitutive production of MMPs; biosynthesis of these enzymes is 
typically induce d by exposure to cytokines [25,26] and growtl1 
factors [26], matrix e lements [27,28], or even 11in cell membrane 
contact with other cell types [29]. Altered physiologic states such as 
wound healing, angiogenesis, and tumor metastasis require expan-
sion of t h e microvasculature . Although MEC share many morpho-
logic and immunologic ch aractetistics with large-vessel endothelia.! 
cells, such as the commonly use d human umbilical vein endothelial 
cells (HUVEC), MEC, when deprived of growth factors , differen-
tiate into capiUa.ry-like structures more readily than do HUVEC 
[30]. They also differ in their modulation of major histocompati-
bility complex antigen and cell adhesion molecule expression [6 ,7] 
and in their response to d e nudation injury [8] . In essence, cultured 
MEC behave more like their in 11i11o counterparts than do large-
vessel cells, and thus, though they are more diffi c ult to isolate, they 
are a more appropriate model of physiologically responsive vascular 
cells. In tllis repor t, we characterize the secretory profile of MEC, 
which exhibit at least some distinctive features from the enzymes 
secreted by large-vessel endotheli al cells. 
MATERIALS AND METHODS 
Reagents Specific reagents and their sources included the following: 1) 
cytokines and growth factors phorbol myristate acetate (PMA; Sigma, St. 
Louis, MO) (20-1 00 ng/ ml) , tumor necrosis factor-a (TN F-a; Genzyme, 
Cambridge, MA) (1 0-1000 U/ml), interferon-")' (IFN--y; Genzyme) (250-
500 U/ml) , basic fibroblast growth factor (bFGF; Genzyme) (10-100 
ng/ml), interleukin (IL)-la (1 00 U / ml) and IL-4 (Genzyme) (1 0-40 
ng/mJ), and transfo rming growth factor-{3 (TGF-{3; Genzyme) (500 pg/ml); 
2) cDNAs for collagenase, stromelysin, 72-kDa gelatinase, and TIMP 
(kindly provided by Gregory Goldberg, Washington University, St. Louis, 
MO) and TIMP-2 eD NA (supplied by William Stetler-Stevenson, National 
Institutes of Health); and 3) matri..x proteins Vitrogen (Celtri.x) and Matrigel 
(Collaborative Biomedical, Bedford, MA). 
Isolation and Culture ofMEC and HUVEC MEC were cultured by a 
method modified from tl1at of Kubota cl nl [30]. Neonatal foreskins were 
obtained from hea lthy male newborns at the time of circumcision. Speci-
mens were cut into 2-3-mm2 sections and incubated in 0.3% trypsin in 
phosphate-buffered saline (PBS). The tissue was then washed several times, 
placed epidermal side down, and processed by gentle downward compres-
sion to release MEC and fragments from the tissue edge. These fragments 
were then layered on a prespun 35% Percoii / Hanks' balanced salt solution 
gradient (30,000 X g for 10 min at 4°C) and centrifuged at 400 X g for 15 
min at room temperature. The fraction ri ch in MEC bas a density of less 
than 1.048 g/ml and was removed. This cellular fraction was then plated on 
a gelatin-coated tissue culture plate in MCDD 131 medium (Washington 
University M edia Center, St. Louis, MO) containing 30% human se.rum 
(Irvine Scientific, Santa Ana, CA), 10 ng/ml epidermal growth fuctor 
(Clonetics Corp., San Diego, CA), l p.g/ ml hydrocorti sone aceta te (Sigma), 
5 X 10- 5 M dibutyryl cyclic AMI' (Sigma), 2 mM glutamine (Irvine), and an 
antibiotic cocktail oflOO U/ml penicillin and 100 p.g/ml streptomycin (Sigma). 
These MEC have cl1e characteristic cobblestone morphology, and more than 
99% of cl1e cells stain positively for von Willi brand fitctor by um11unohisto-
chemistry (Factor VIJJ-related antigen; Dako, Glostrup, Denmark). 
HUVEC were isolated from collagenase-treated human umbilica l veins 
accordu1g to the method described by Jaffe el nl [31] . Cells were cultured in 
medium 199 (Washington University Media Center) with 20% fetal bovine 
serum (Gibco), 100 p.g/ ml endothelial growth supplement (Collaborative 
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Research), 50 p.g/ml heparin (Elkins-Sinn, Cherry Hill , NJ), 2 mM 
glutamine (Irvine), and an antibiotic cocktail of1 00 U/ml penicillin and 100 
p.g/ml streptomycin (Sigma). Before their usc in experiments, HUVEC 
were maintained in MEC medium without hydrocorti.sone for at least 24 h. 
HMEC-1 is a human microvascular endocl1e lial cell line (generous gift of 
Dr. Thomas Lawley, Department of Dermatology, Emory University, 
Atlanta, GA) transfonned wicl1 polyoma T tl1at has many of the character-
istics of primary cultured MEC [32]. These cells were maintained and 
passaged in MCDB 131 basal medium, supplemented with 10% human 
serum (Irvine), 10 ng/ ml epidermal growth f.1ctor (Clonetics Corp.), 1 
J.Lg/ml hydrocortisone acetate (Sigma), 2 mM glu tamine (Sigma), 100 U/ml 
penicill in , and 100 p.g/ml streptomycin (S igm a). 
Measurement of Secreted Metalloproteinases by Enzyme-Linked 
Immunosorbent Assay (ELISA) and Immunoprecipitation of Met-
abolically Labeled Cells Primary endocl1elial cells were used at passage 
2-6 and were grown to confluence in gelatin-coated (unless otherwise 
specified) si.x-well tissue culture plates (CoStar, Cambridge, MA) . To 
standardize experimental conditions, we maintained all ceLl types in hydro-
cortisone-free MEC medium for at least 24 h before cytokine or growth 
factor stimulation . The removal of hydrocortisone was necessary because it 
inhibits meta lloproteinase production in most cell types (33]. Once passed 
and pla ted, endothelial cell s grow normally in the absence of steroid. 
Monolayer cultttres were treated with cytokines or growcl1 factors for 72 h, 
and the ceLl supernatants were harvested for metnlloproteinase determina-
tions. Interstitial collagenase, stromelysin, 92-kDa gelatinase, and T IMP 
were quantified using established ELISAs [34,35] . These assays have a 
sensitivity of approximately 10 ng/ml and quantify cl1e total amount of each 
protein species, whether free or bound to substrate o r u1 the form of an 
enzyme-inhibitor complex. 
Enzyme biosynthesis was eva luated by metabolic labeling of cell cultures 
with [35S]mecl1ionine (5 mCi/ml) (ICN Phannaceuticals, Irvine, CA) and 
subsequent immunoprecipitation using specific polyclonal antisera. Endo-
thelial cell monolayers were exposed to cytokines or growth factors for a 
tota l of 48 h . For the final 24 h of incubation, (35S]mcthion.ine was added to 
methionine-free MEC medium containing dialyzed human serum and fresh 
cytokines. Cell culture supernatants were collected, and immunoprecipita-
tion was perfonued as described [36). 
Gelatin Zymography MEC and HUVEC were plated at identica l ce ll 
numbers and grown to confluence in six-well gelatin-coated tissue culture 
dishes (Costar). Once confluent, the cells were placed in hydrocortisone-
free, serum-free MEC medium with or wicl10ut PMA (20 ng/ml). After 24 
h, conditioned medium was collected and assayed by gelatin Z)'l110!,'Taphy for 
the activity of 72-kDa and 92-kDa gelatinases, as described previously [3 7]. 
Migration Assay A modified migration assay [38] was perfom1ed by 
plating MEC on Vitrogen-coated (1 mg/ml) (Celtri..x Laboratories, Palo 
Alto, CA) one- well Permanox Lab-Tek chamber slides (Nunc Inc., Naper-
ville , lL) and the cells were aUowed to reach confluence. The central 
portion of the confluent monolayer, along with the underlying matrix, was 
then removed with a cell scraper (Costar), creating a wound. The control 
and wounded monolayers were re-fed with M.EC medium without hydro-
cortisone with or without 100 U /ml TNF-a. Endotheli<tl cell migration 
from the wounded edge was evident by 24-72 h post-wounding. at which 
time the cells were washed with PBS and fixed in 10% buffered forn1alin 
before processing for iu si/11 hybridization. 
lu Situ Hybridization and Immunohistochemistry After fixation, 
cell monolayers were processed for iu sit 11 hybridization, as reported 
previously [39]. Briefly, formalin-fixed cell monolayers were washed, 
nonspecific sites were alJ...}'Iated with acetic anhydride, and samples were 
incubated in hybridization buffer containing 5 X 105 cpm of e5S]-Iabelcd 
antisense RNA overnight at 42°C. Control slides were processed with 
labeled sense RNA. Specimens were theu washed repeatedly under strin-
gent conditions and processed for autoradiography. HematO"-}'Iin and eosin 
countcrstain.ing was performed to visualize cell morphology. 
For immunopcroxidase staining, the cell monolayers were rehydrated in 
PBS and endogenous peroxidase activity was blocked by incubating the 
slides in 0. 75% hydrogen-peroxide- containing PBS; followed by 0.1 'Vo 
trypsin incubation. Nonspecific binding was blocked witlt the appropriate 
animal serum. Cell monolayers were incubated \vith monoclonal mouse 
anti-human von Willebrand fuctor (Dako) overnight at 4°C . The Vectastain 
ABC kit (Vector Laboratories, Burlingame, CA) for mouse IgG was used for 
secondary antibody stauti.ng, and developing was perfom1ed wicl1 3,3 '-
diaminobcnzidine (Vector). 
RNA Isolation and Northern Hybridization Total cellular RNA was 
isolated from experimental cells by guanidinium-isocluocyanate-phenol 
extraction and ethanol precipitation L 40] and quantified spectrophotometri-
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ca ll y. Northern blots were performed and probed with random-primed 
r32P]dCTP-labeled eDNA fragments specific for collagenase, stromelysin, 
72-k.Da gelatinasc, TIMP-1, and TIMP-2 . Glyceraldehydc-3-phosphate 
deh yc:!rogenase (GAPDH) probing of membranes was. used to assess unifor-
mity of RNA loading and transfer. 
Chloramphenicol-Acetyl Transferase (CAT) Assays HMEC were 
transiently co-transfcctcd with the CAT reporter gene construct, pCLCAT, 
containing 2.28 kB of the 5' regul ato ry re1,rion of the collagenase gene, 
which includes the transcription start site, a TATA box, an AP-1. site , a 
PEA-3 site . and an NF1<B-like site [41] , and with CMV {3-galactosidase. We 
also used pCAT (Promega, Madison , WI). a nonco ll agenase-based positive 
control that is driven by the SV 40 promoter and enhancer. T he construct 
pCLCAT, containing sequences frorn - 2278 to + 36 of the human collag-
enase promoter, was a generous g ift from Dr. Stephen Frisch. The 
Hi,dlll / X hoi fragment containing the human coLla genase promoter se-
quences ofpCLCAT was subcloned into HiHdlii/X/Jol-digested pBLCAT2, 
giving rise to pC L-2278CAT. A C MV promoter-driven J3-galactosidasc 
vector was used to allow norn1:.liz arion for transfection eftlciency . 
Cells were plated at 3-5 X 1 05 cells/we ll in a six-well cluster tissue 
culture dish . Transfections were perfom1ed with 2 JJ.g of each plasmid and 
1 JJ.g of C MV-J3-galactosidase 11ia liposome fusion using lipofectAMINE 
(Gibco-BRL, Gathersburg, MD), as described previously [42]. Cells were 
exposed to lipofcctAM LN E/plasmids in serum-free and antibiotic-free 
MCDB 131 medium containing glut;u11in.e , hydrocortisone, and epidermal 
growth fa ctor at the concentrations described above (see i\ilalerinls n111l 
Met /10ds) for 6 h and then supplemented with 5'% human serum . Approxi-
mately 24 h after transfection , the medium was replaced with serum-
supplemented medium with or without PMA (20 ng/ ml) or TN F-a (1 00 
U/ ml). Lysa tes were prepared at 48 or 72 h after tramfcction (24 or 48 h 
after stimulation) in "100 mM KP0 4 /1 mM dithiothreitol by repeated 
freeze-thaw cycles after washing twi ce with PBS to remove nonviable cell s. 
The J3-ga lactosidase assay was performed to normalize CAT activity [43] . 
CAT reaction mix tures we!·e prepared by incubation of lysate with 0.25 M 
Tris·CI, 14 C-Iabcled chloramphenicol (1. J.LCi/ml) (DuPont, Boston, MA) , 
and acetyl Co-A (S igma) at 37°C ove rnight. After cthyl acetate partition and 
evaporation , acctylated form s of ch.loramphenicol were resolved by thin-
layer chromatography and dcmonst,·a tcd by autoradiography. CAT activity 
was quantified by cutting the radioac tive spots from the thin-laye r chroma-
rognphy plate and measuring the an,ount of radioactivity. 
RESULTS 
Modulation of Metalloproteinase and TIMP Production by 
MEC and HUVEC Endothe lial cells con sti tutively expressed 
sma ll amounts of interstitia l collagen ase and stromelysin . As shown 
in Figs 1 and 2, phorbol ester markedly stimulated the production 
of interstitial co llagenase and stromelysin in both MEC and 
HUVEC. Augmented expression of these proteins was demon-
strated by EUSA and by imrnm10precipitation of metabolically 
labeled proteins. Small- a11d la rge-vessel endothelial cells showed 
similar capacities to produce inte rstitial collagena se after phorbol 
stimulation. In at least four separate experiments, 72 h of PMA 
exposure m ediated a more than fivefold increase in collagenase 
production in MEC and HUVEC (Fig 1). Stromel ysi.n exhibited a 
similar though lesser stimulation of expression in response to PMA 
(Fig 2) . It is interes ting that activation of secreted stromelysin was 
prominent in MEC after P~ stimulation (Fig 2, dot~blc bal"ld), 
suggesting that .MEC m ay possess the capacity to activate this MMP. 
To assess the production of 92-kDa and 72- kDa gela tinases by 
endoth elial cell s, we p erform e d gelatin zymography. Medium from 
MEC and HUVEC plated und e r serum-free condition!i with or 
without PMA stim ulation w as :Jssayed as described in Material.~ a11.d 
Methods. As shown in Fig 3, signifi cant gelatinase activ ity was 
absent in M EC control medium; control HUVEC produced low 
levels of 72-kDa gelatinase. After PMA exposure, however, 92-
kDa gelatinase ac tivity was obse rved in both endothelia l cell types, 
as was gelatinolytic activi ty deriv e d from inte rstitia.! collagenase . As 
evaluated by immunoprecipita tion , 92-kDa gelatinase was not 
con stitutively expressed by sm a.U- or large-vessel endothelial cells 
but was induced after PMA exposure. PMA induction of 92-kDa 
gelati nase expression was e nhanced when MEC were plated on 
type J collagen and Matrigel (basement-membrane-like substra-
tum) (Fig 4) . Because m e tabolic labeling and immunoprecipitation 
detect ac tive cell biosynthesis only, the in creased immunoprecipi-
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I Cnt PMA TNF lFNy I Cnt PMA TNF IFN·r I 
MEC HUVEC 
Figure 1. PMA and TNF-a stimulate collagenase production in 
MEC and HUVEC. A, MEC (n = 6) and HUVEC (n = 4) monolayers 
were treated at conAuen ce with PMA (20 ng/ml) for 72 h in MEC medium . 
Cell supernatants were then ana lyzed for collagenase content by ELISA. 
Collagenase expressed relative to contTol conccntratiou = 1. E11"01" bars. SEM. 
B, MEC and 1-IUVEC in a single experiment were plated at identical cell 
numbers and stimulated with PMA (20 ng/ml) , T N F-a (1 00 U/ml), or IFN-)' 
(500 U/ ml). Cells were metabolically labeled wid1 [35S]methioninc, :md the 
conditioned medium was subjected to immunoprecipitation with collagenase 
antiserum. A1wwhend indicates collagenase-specific band. Cnt, control. 
table material fi:om cells p lated on Matrigcl is not derived from 
gelatinase activity that may be present in the matrLX [44 ,45). 
MatriJysin was not produced by MEC or HUVEC under basal or 
stimulated conditions (assessed using Matrilysin-spec ific antiserum; 
data not shown). 
We next exa mined the production ofTIMPs by endothelial cells. 
A s shown in Fig 5, TIMP produ ction in MEC was up-regulated in 
response to PMA, whereas TIMP-2, constitutively expressed by 
both small- and large-vessel endothelial cell s, was down-regulated 
by phorbol. PMA induction of collagenase, stromelysin, and TIMP 
was a lso seen in HMEC-1, the microvascular endothelial cell line 
(data not shown) . 
E ndothelial ce ll metalloenzyme production was also modulated 
by TNF-a, which regulates several activities of endothe]jal cells 
[6 ,46,47]. TNF-a appeared to fun ction with near equiva lence to 
PMA in the induction of stromelysin (Fig 2) but was less e ffe ctive 
than PMA in stimulating collagenase biosynthesis in MEC (Fig 6A) 
unless used at n onphysiologic concen trations (Fig 6B) . PMA and 
TNF-a w ere additive in their actions o n co\Jagenase production 
(Fig 6A). TNF-a a lso up-regulated coll agenase in HMEC-1 (data 
not shown) . In addition, bFGF, a gwwth factor w ith known 
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I Cnt PMA TNF IFNy I Cnt PMA TNF IFNy 
MEC HUVEC 
Figure 2. PMA and TNF-a increase stromelysin production in 
MEC and HUVEC. MEC and I-IUVEC w ere plated at identical ce ll 
numbers and tr<:atcd with PMA (20 ng/ ml) , TNF-a (100 U / ml) , or IFN-y 
(500 U / ml). Cells were metabol.ically labeled with 13 5S)meth.i onine, and the 
conditioned medium was subjected to immunoprccipitation with stromcly-
sin antiserum. AITOIII!wnd indica tes stromelys in-spccific band. C nt, contro l. 
angiogenic effects, stimulated collagenase biosynthesis in MEC; tl:tis 
up-regulation was inhibited by TGF- {3 (Fig 6B). TNF-a had 
minimal to no effect on constitutive T IMP biosynthesis but down-
regulated TIMP-2 production (Fig 5). TNF-a also inhibited the 
PMA-stimulated production ofTIMP (data not shown). IL-4 tested 
at 10-40 ng/ ml did not affect collagenase , stromclys in , TIMP-1, or 
T IMP-2 production in MEC or HUVEC. 
IFN-y is a lymphokine with well-recognized effects on endothe-
lial ce lls [6,46]. At biologically relevant concentrations (250-500 
U/ml), IFN-y potently inhibited the TNF-a -induced production 
of collagenase (Fig 6A). In contras t, IFN-y up-regulated TIMP 
biosynthesis in M.EC and HMEC-1, but not in HUVEC (Fig 5). 
Pretranslational Regulation of Metalloproteinase and 
TIMP Expression To assess pretranslational regulation of met-
alloproteinase and TIMP in endothelial cells, we performed North-
43-
30-
20-
14-
Cnt PMA 
MEC 
Cnt PMA 
HUVEC 
92 kDa 
72kDa 
c'ase 
Figure 3. MEC secrete 92-kDa and 72-kDa gelatinase activity. 
Gelatin zymograp hy was performed using medium fro m MEC and HUVEC 
obtained under serum-free cond.itions for 24 h with or without PMA 
stimulation (20 ng/ ml). No significant ge latinase acti vity was observed in 
contro l MEC medium ; 72-kDa gclatinase activity w as detected in contro l 
HUVEC medium. PM A-stimulatcd MEC and HUVEC produced 92-kDa 
gelatinase activ ity. Collagenase activity was al so observed in the control and 
PMA-treatcd cell s. Cnt, controL 
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HUVEC 
GEL II COLI II MGL 
F igure 4. Substrate-spedfic biosynthesis of 92-kDa gelatinase in 
response to phorbol esters. MEC and H UVEC were plated on various 
matrices and allowed to reach conflue n ce before stimulation . At 24 h after 
PMA stimulation o n va rious m atrices, 92-kDa ge latinase production was 
evaluated by [35S]methionine p ulsing a nd subsequent immunoprecipitation. 
GEL, ge latin ; COL I, native type I collagen; MGL, MatrigeL 
em analysis. Total RNA extracted from confluent cultures ofMEC, 
HUVEC, and HMEC revealed low constitutive levels of collage-
nase mRNA, with markedly increased expression after 24 h of 
PMA exposure . Treatment with T NF-a and bFGF also increased 
collagenase mRNA by approximately two- to threefold, an increase 
consistent with protein da ta (Fig 7) . GAPDH probing was per-
form ed to confirm uniformity of loading and transfer. Stromelysin 
and TlMP mRNA levels were also up-regulated by PMA (data not 
shown) . Consistent with the protein data shown previously (Fig 5), 
T JMP-2 mRNA was decreased by treatmen t of MEC with PMA 
(data not shown). 
Collagenase mRNA Is Expressed in Migrating MEC In Vitro 
I11 situ hybridization was performed on MEC monolayers that were 
wounded as described in Materials a11d Methods. Occasional endo-
thelial cells w ere weakly positive for collagenase mRNA in UJ1-
treated control monolayers, w he reas in cultures treated with 
T N F- a (100 U/ml) for 48 - 72 h , scattered individu al cells had 
signal for collagenase mRNA. En.dothelial cells of the untreated, 
wounded monolayers expressed collagenase mRNA in som e of the 
migrating ce!Js adjacent to the wounded edge. However, in the 
monolayers that were simu]taneously stimulated by wounding and 
T NF-a , high levels of collagenase mRNA w ere expressed in 
groups of endothelial cells adjacen t to the wounded edge; the signal 
strength diminished rapidly away fro m this edge (Fig 8). 
Collagenase Production Is Transcriptionally Regulated in 
Endothelial Cells As reported previously, the 5' flanking region 
of the co!Jagenase gene contains a functional promoter as well as 
PMA-responsivc e lement(s) [48 - 51]. HMEC were transfected with 
a CAT gene construct containing 2.28 kb of the collagenase 
promoter (WT-CL-CAT). Para!Jel.ing the protein and mRNA data, 
MEC HUVEC 
TIMP 
TIMP-2 
Figure 5. Disparate regulation of TIMP-1 a nd TIMP-2 by PMA. 
MEC and I-IUVEC were plated at identical cell numbers and stimulated 
w ith PMA (20 ng/ml) , T NF-a (100 U/ml), or IFN-y (500 U / ml). Cells 
were metabo lically labeled with [35S]methionine, and the conditioned 
mec:tium was subjected to immunoprecipitation with T IMP <Jnd T IMP-2 
antiserum . C ut, controL 
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Figure 6. PMA and TNF-a stimulate collagenase production addi-
tively; IFN--y inhibits TNF-mediated collagenase expression. A, 
MEC were plated to confluence and exposed to PMA (20 ng/ml), T NF-a 
(1 00 U / ml), PMA (20 ng/ml) + IFN--y (500 U/ml), or TN F-a + IFN-y 
(500 U/ml). Cells were metabolically labeled with [35S]methionine, and the 
conditioned medium was subjected to immunoprecipitation with collage-
nase antisenun. An·owltend indicates col.l agenase-spccific band . B, MEC were 
plated to confluence and exposed to PMA (20 ng/ml) , TNF-a (100-1000 
U/ml), bFGF (30 ng/ ml), TGF-(3 (500 pg/ml), or bFGF (30 ng/ml) + 
TGF-{3 (500 pg/ml). Ccl.l s were metabolically labeled with e5 S]methionine, 
and the conditioned medium was subjected to UT)munoprecipitation with 
collagenase antiserum. A11'owltend indica tes collagenase-specific band. C nt, 
controL 
.· 
PMA and TNF-a increased CAT activity. Again, PMA was more 
effective in driving CAT production than was TNF-a (Fig 9). T h e 
pCA T construct, driven by an SV 40 promoter, served as a positive 
control for transfectiol1 that was not regulated. 
DISCUSSION 
By employing various teclmiques, including ELISA and inm1Uno-
precipitation, Northem hybridization, in siiH hybridization, and 
transient transfection assays, w e studied the spectrum of metaJlo-
proteinases produced by endoth e lial cells and the factors regulating 
their biosynthesis. With minor exceptions, we found that both 
small-vessel (MEC) and la.rge-vessel (HUVEC) endothelia l cells 
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Figure 7. Pretranslational regulation of collagenase expression. A, 
MEC, HUVEC, and 1-IMEC were stUnulated for 24 h with PMA (100 
ng/ml), after which total cellular RNA was harvested and analyzed (5 J.Lg) 
for relative collagenase mRNA expression by Northern hybridization. 
GAPDH probing was used to indicate uniformity ofloading and transfer of 
mRNA. B, Northern blot analysis was perfonned on MEC after 24 h 
stimulation with PMA (20 ng/ml) , TNF-a (100 U/ml), and bFGF (100 
ng/ml), as in A .. Cnt, control. 
e laborate a similar profile of MMPs whose regulation is subj ect to 
modification by cytokines and growth factors, su ch as TNF-a, 
bFGF, and IFN-y. Taken as a whole, the similarities in response of 
MEC and HUVEC to physiologically relevant agents far outweigh 
the small differences found. 
Our studies using both protein and mR.NA assays demonstrate 
that endothelial cell metalloproteinase and TIMP production is 
controlled at a pretranslational leveL Regulatory modifiers of 
collagenase, stromelysin, TIMP, and TIMP-2 production aU acted 
in tlus manner. In the case of collagenase expression in MEC after 
exposure to PMA, control by transcriptional activation was also 
demonstrated. Auble and Brinckerhoff [51] have reported that the 
AP-1 sequence within the 5' region of ti1.e collagenase gene is 
necessary, but not sufficient, for phorbol induction of the collage-
nase gene in fibroblasts. T h ese investigators and Gutman and 
Figure 8. Collagenase mRNA is up-regulated in migrating MEC 
that are exposed to TNF-a. A modified migration assay was performed 
as described in Mnterials a11d Methods . MEC were plated to confluence on 
Vitrogen-coated Lab-Tek chambers, stunulated by "wounding" with or 
without TN F-a (1 00 U/ml), and subsequently probed witl1 (35S]-labeled 
antisense collagenase RNA. lu situ hybridization for collagenase mRNA on 
the TNF-treated , wounded endothelial cell monolayer (darkfield, lOO X) 
showed a gradient of collagenase mRNA expression with greatest e"'Pres-
sion at the wounded edge. W, wmmd; small nnows, positive cells; opeu nn·ow, 
negative cell ; large nt'I'OII', direction of cell migration. 
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Figure 9. Collagenase production is transcriptionally regulated in 
endothelial cells. A, HMEC were plated at 5 X 105 cells/well in six-well 
cluster dishes and transiently transfected with WT-CL-CAT, containing 
2.28 kb of the 5' reguJatory region of the collagenase gene. PMA (20 
ng/1111) or TN F-a (1 00 U/ml) was added for 24 h. Cells transfected with 
pCAT, a noncollagenasc-based positive control , did not show regulation . 
Percent acerylation of WT -CL-CAT transfections is shown (n = 6). El7'or 
bars, SEM. B. representative experiment ofWT-CL-CAT transfection after 
48 h treatment with PMA (20 ng/ml) or TNF-a (1 00 U / ml). Cnt, control. 
Wasylyk [41] further reported that the PEA-3 and "TTCA" cis 
elements were also important for phorbol induction. Collagenase 
promoter activity was also consistently elevated after transfection 
with WT -CL-CAT and treatment with TN F-a, suggesting tran-
scriptional activation (Fig 9). The increases in CAT activity 
observed correlate well with the fold induction of collagenase 
mRNA by TNF-a. However, the fold increase in collagenase 
promoter activity in these experiments may actually be underrep-
resented because of the use ofCMV-J3-galactosidase cotransfection 
for normalization of CAT activity. This CMV-J3-galactosidase 
construct contains an AP-1 site, which may be responsive to TNF-a 
in our experiments, effectively causing underestimation of stimula-
tion of the collagenase promoter activity, whjch may be mediated 
by AP-1. Through gel-shift assays, we have recently found that 
treatment of HMEC with TNF-a does, in fact, induce protein 
binding to the AP-1 consensus sequence of the collagenase gene 
(unpublished observations). In fibroblasts, transcriptional regula-
tion of collagenase by TNF-a has been demonstrated to occur 
through binding of c-jurlic-Jos heterodimers to the AP-1 site [49] . 
Our data are the first to suggest that in MEC, PMA- and possibly 
TNF-a-responsive element(s) in the 5' region of the collagenase 
gene are functional. 
MMP may in fact have an important role in facilitating cell 
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migration during vascular remodeling and angiogenesis; a physio-
logic role for endothelial cell proteases in these processes has been 
proposed . Mjgnatti ct a/ [52] have reported the requirement for 
bFGF-induced proteases in an ;, 11itro angiogenesis system, the 
human amruotic membrane. More recently, Schnaper et a/ [ 44] 
have shown the presence of 72-kDa gelatinase after the induction 
of endothelial cell tube formation on Matrigel. In the present study, 
we have shown that TNF-a, another known stimulator of angio-
genesis [53], increases collagenase and decreases TIMP production 
;, 11itro. As determined by our protein and Northern hybridization 
data, physiologically relevant dosages of TNF-a and bFGF rou-
tinely increased MMP e:\.'Pression two- to threefold. In contrast , as 
demonstrated by our migration assay and i11 situ hybridization 
findings, actively migrating MEC, in the presence of TNF-a, 
expressed markedly increased amounts of collagenase mR.NA. In 
fact, an area of rugh-collagenase-produ cing cells that were simul-
taneously migrati11g and exposed to TNF-a was established along 
the wounded surface, as compared with those cytok.ine-treated cell s 
removed from the wounded edge (Fig 8). 
We suggest that endothelial ceU migration is an important early 
event in vascular neogenesis and that such migration is dependent 
upon and facilitated by meta.lloproteinase expression . As with most 
cell types studied to date, in the basal state, constitutive levels of 
endothelia] cell metalloprotinases are low and accompanied by 
specific inhibitors. When angiogenesis is injtiated by modulators 
such as bFGF and TNF-a, the induction of endotheHal cell 
collagenase may be required for cell migration through connective 
tissues. Enzyme levels may then return to base line and/or TIMP 
levels may increase once the actual vascular structure is formed . 
It is tempting to postulate that in wound healjng, the early 
recruitment of monocytes and the release of TN F-a induce endo-
thelia.! cell collagenase production and concomitantly inhibit TIMP 
production, thus favoring a migratory phenotype by the endothelial 
cell. In fact, macrophage-induced angiogenesis has been reported 
to be mediated by TNF-a [54]. With regard to other inflammatory 
cells, lymphocytes are recrujted late and release varying substances, 
including IFN--y. As we have shown, this physiologic regulator of 
endotheHal cell function abates cytokine-induced metal.loproteinase 
expression and simultaneously in creases TIMP and TIMP-2 pro-
duction. Consistent with trus, Niedbala and Picarella [55] reported 
that IFN--y blocks TNF-a-induced proteolysis of extracellular 
matri..x mediated by endothelial cell urokinase-type plasmjnogen 
activator. 
Mediators of MMP expression may also affect migration of 
endothelial cells by modulati11g matrix receptors. It is interestin g 
that bFGF, TNF-a and IFN--y have also been reported to regulate 
avJ33, the vitronectin receptor [56]. Similarly, Sepp eta/ [57] have 
found that bFGF, wluch stimulates collagenase production in MEC, 
down-regulates the a6J34 complex on these cells, allowing detach-
ment from the basement membrane. Previous work by Enenstein et 
a/ [58] found that bFGF up-regulates the collagen / laminin receptor 
(a2J31) in these same cells. Taken together, these integri.n re-
sponses, induced by physiologically relevant cytokines and growth 
factors with well-recognjzed angiogenic properties, aid i11 produc-
ing a migratory phenotype by decreasing endotheHal cell adhesion 
to the basement membrane and facilitating migration through th e 
interstitial matrix. Based on these collective findings, it is interest-
ing to propose that metalloproteinase induction, TIMP inhibition, 
extracellular matrix proteolysis, and integt;n down-regulation are 
active in early angiogenesis, when endothelial cell migration is the 
primary event. The fmal stage of angiogenesis involves vessel 
formation, endotheHal cell matrix deposition ancf stabilization, and 
is accompanied by a down-regulation of matrix-degrading metal-
loproteinases together with an induction of protease i.nbjbitors. 
Tlris work wns mppottcd b)' grnuts AR35805 nud HL29594 fimu tire Nnrimrnl 
lustitutes of Ht•alr,. Dr. Come/ius is tire recipielll ~f n Cnreer D ePrloputettl Awnrd 
from tire Denuarology Fouudntio11 (1994). 
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